Inventiva
Clinical-stage biopharma developing oral small molecule therapies for unmet needs.
IVA | PA
Overview
Corporate Details
- ISIN(s):
- FR0013233012 (+2 more)
- LEI:
- 969500I9Y690B3FZW590
- Country:
- France
- Address:
- 50 RUE DE DIJON, 21121 DAIX
- Website:
- https://inventivapharma.com/
- Sector:
- Manufacturing
Description
Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for diseases with significant unmet medical needs. The company's primary therapeutic areas include fibrotic diseases, lysosomal storage disorders, and oncology. Its lead product candidate, lanifibranor, is a pan-PPAR (peroxisome proliferator-activated receptor) agonist being evaluated in a pivotal Phase III clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). Lanifibranor is designed to address the key features of NASH, including steatosis, inflammation, ballooning, and fibrosis. The candidate has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) based on positive Phase IIb results.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-15 11:17 |
Franchissements de seuils
|
French | 144.1 KB | ||
| 2025-12-15 10:50 |
Franchissement de seuils
|
French | 129.5 KB | ||
| 2025-12-15 10:41 |
Franchissement de seuils
|
French | 129.7 KB | ||
| 2025-12-05 15:38 |
Franchissement de seuil
|
French | 129.2 KB | ||
| 2025-12-02 16:31 |
Franchissement de seuil
|
French | 128.3 KB | ||
| 2025-12-01 16:00 |
Franchissement de seuils
|
French | 128.5 KB | ||
| 2025-11-28 15:56 |
Franchissement de seuils
|
French | 120.1 KB | ||
| 2025-11-28 15:42 |
Franchissement de seuils
|
French | 121.1 KB | ||
| 2025-11-28 15:25 |
Franchissement de seuils
|
French | 110.0 KB | ||
| 2025-11-28 08:30 |
Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 27…
|
French | 232.1 KB | ||
| 2025-11-28 08:30 |
Results of the Votes of the Combined Shareholders’ General Meeting of November…
|
English | 247.6 KB | ||
| 2025-11-21 22:00 |
Inventiva publie ses informations financières du 3ème trimestre 2025¹
|
French | 270.1 KB | ||
| 2025-11-21 22:00 |
Inventiva reports 2025 Third Quarter Financial Information¹
|
English | 279.2 KB | ||
| 2025-11-21 11:21 |
Franchissement de seuil
|
French | 108.9 KB | ||
| 2025-11-21 11:20 |
Franchissement de seuils
|
French | 110.8 KB |
Automate Your Workflow. Get a real-time feed of all Inventiva filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inventiva
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inventiva via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-04-05 | N/A | Other | Buy | 10,000 | N/A |
| 2023-12-08 | N/A | Other | Buy | 15,000 | N/A |
Peer Companies
